Tech Transfers for biological products, whether they occur from a pharma company, another CMO, or a different site within the same organization, are complex and challenging processes.
Join us for an insightful webinar on the critical aspects of technology transfer of either drug substance or drug product. This session will delve into the strategies and best practices for seamless tech transfer processes, ensuring regulatory compliance, and maintaining product quality and consistency.
Jump to: Full webinar highlights
Preview this webinar
Get immediate access to the full webinar by filling out the form on this page.
Full webinar highlights
Get immediate access to the full webinar by filling out the form on this page.
We will explore real-world case studies highlighting innovative solutions to
- Accelerate clinical tech transfer for drug products, enabling a released clinical batch within five months from kick-off
- Seamless process transfer for at-scale 2kL GMP manufacturing with parallel process development for enhanced cell culture titre and reduced material cost
Additionally, we will focus on the unique challenges of biologics manufacturing, discussing the intricacies of transferring complex biologic drug substances from development to large-scale production. Learn about the specific considerations for maintaining the stability, efficacy, and safety of biologics throughout the tech transfer process.
Key Learning Objectives
- Gain valuable insights into optimizing tech transfer efficiency, overcoming regulatory hurdles, and ensuring a smooth transition to clinical and market supply
- Provide valuable knowledge and practical tools to enhance your tech transfer efficiency and success
- Learn from industry experts and optimize your tech transfer practices